Scans with Intravenous Contrast Agents Seldom Cause Clinically Significant Kidney Injury

Earlier studies have shown that the administration of contrast dye into blood vessels can cause acute kidney injury, or the rapid loss of kidney function due to damage to the kidneys. However, this research has conventionally been conducted in patients undergoing angiographic procedures that are done to detect abnormalities in the blood vessels. Less is known about the risk of acute kidney injury in outpatients who receive intravenous dye for CT scans. These data would be beneficial to physicians, because patients who are considered at risk of kidney injury from these procedures should receive certain preventive interventions.

To fill this gap in knowledge, Dr. Steven Weisbord and his colleagues of the department of Veterans Affairs (VA) Pittsburgh Healthcare System (PA, USA) and the University of Pittsburgh School of Medicine (PA, USA) attempted to determine the incidence of acute kidney injury due to intravenous dye in individuals undergoing CT scans. They conducted a prospective, observational study of 421 patients within the VA Pittsburgh Healthcare System who did not have end-stage renal disease and who were scheduled to undergo CT scans with intravenous dye. They evaluated kidney injury by measuring the amount of creatinine found in the blood. Creatinine is a muscle breakdown product that is filtered by the kidneys; high levels in the blood indicate kidney dysfunction.

In monitoring patients' creatinine levels after the procedures, the researchers reported that only 0.5% of patients had a 50% or more increase in creatinine blood levels, and none had a 100% increase. Contrast-induced acute kidney injury was not uncommon in the subset of patients who were hospitalized or who had advanced kidney impairment before the CT scan. However, kidney injury was very uncommon in outpatients with mild baseline kidney disease. Even when patients did develop contrast-induced acute kidney injury, none required dialysis and none were hospitalized or died because of the kidney disease.

"These observations have important implications for providers ordering and performing computed tomography and for future clinical trials of contrast-induced acute kidney injury in patients undergoing this radiographic procedure,” the authors wrote in their article. They observed that their findings will help clinicians determine which patients are at risk for acute kidney injury and will help make sure that intravenous dye is used in the safest possible manner.


Related Links:
Veterans Affairs Pittsburgh Healthcare System
University of Pittsburgh School of Medicine